Hedgehog signaling plays a dual role in pancreatic carcinogenesis

Tara L. Hogenson, Rachel L.O. Olson, Martin E Fernandez-Zapico

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The hedgehog (Hh) pathway plays an important role in a wide variety of developmental processes including cellular differentiation and tissue patterning. While Hh signaling is a critical component of embryonic development, this pathway is not typically active in most adult tissues. Inappropriate Hh signaling has been associated with several types of malignancies including pancreatic ductal adenocarcinoma (PDAC). In PDAC, the Hh pathway is activated by two distinct mechanisms in the tumor epithelial and stromal compartments. In the stroma, the Hh pathway activity is induced by its ligands in a canonical fashion; in tumor epithelial cells its activity is regulated in a ligand-independent manner by known PDAC oncogenic cascades including KRAS, TGFß, and EGFR signaling. Initial preclinical studies demonstrated that the Hh pathway may be a promising therapeutic target for PDAC. However, Hh inhibition has not been successful in clinical trials of PDAC patients with advanced metastatic disease. Recent reports indicate the Hh pathway may play a dual role in carcinogenesis, acting as an oncogene in early tumorigenesis while switching to a tumor suppressor as the cancer progresses. Current research efforts are aimed at further understanding the role of the Hh pathway in all stages of carcinogenesis and defining the translational value of Hh inhibition in PDAC.

Original languageEnglish (US)
Title of host publicationPancreatic Cancer
PublisherSpringer New York
Pages409-430
Number of pages22
ISBN (Electronic)9781493971930
ISBN (Print)9781493971916
DOIs
StatePublished - Apr 11 2018

Fingerprint

Carcinogenesis
Adenocarcinoma
Neoplasms
Ligands
Oncogenes
Embryonic Development
Epithelial Cells
Clinical Trials
Research
Therapeutics

Keywords

  • EGFR
  • GLI1
  • GLI2
  • GLI3
  • Hedgehog
  • KRAS
  • TGFß
  • Tumormicroenvironment
  • Vismodegib

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Hogenson, T. L., Olson, R. L. O., & Fernandez-Zapico, M. E. (2018). Hedgehog signaling plays a dual role in pancreatic carcinogenesis. In Pancreatic Cancer (pp. 409-430). Springer New York. https://doi.org/10.1007/978-1-4939-7193-0_76

Hedgehog signaling plays a dual role in pancreatic carcinogenesis. / Hogenson, Tara L.; Olson, Rachel L.O.; Fernandez-Zapico, Martin E.

Pancreatic Cancer. Springer New York, 2018. p. 409-430.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hogenson, Tara L. ; Olson, Rachel L.O. ; Fernandez-Zapico, Martin E. / Hedgehog signaling plays a dual role in pancreatic carcinogenesis. Pancreatic Cancer. Springer New York, 2018. pp. 409-430
@inbook{c2594ae40a254eccb84b9043dc95e4c4,
title = "Hedgehog signaling plays a dual role in pancreatic carcinogenesis",
abstract = "The hedgehog (Hh) pathway plays an important role in a wide variety of developmental processes including cellular differentiation and tissue patterning. While Hh signaling is a critical component of embryonic development, this pathway is not typically active in most adult tissues. Inappropriate Hh signaling has been associated with several types of malignancies including pancreatic ductal adenocarcinoma (PDAC). In PDAC, the Hh pathway is activated by two distinct mechanisms in the tumor epithelial and stromal compartments. In the stroma, the Hh pathway activity is induced by its ligands in a canonical fashion; in tumor epithelial cells its activity is regulated in a ligand-independent manner by known PDAC oncogenic cascades including KRAS, TGF{\ss}, and EGFR signaling. Initial preclinical studies demonstrated that the Hh pathway may be a promising therapeutic target for PDAC. However, Hh inhibition has not been successful in clinical trials of PDAC patients with advanced metastatic disease. Recent reports indicate the Hh pathway may play a dual role in carcinogenesis, acting as an oncogene in early tumorigenesis while switching to a tumor suppressor as the cancer progresses. Current research efforts are aimed at further understanding the role of the Hh pathway in all stages of carcinogenesis and defining the translational value of Hh inhibition in PDAC.",
keywords = "EGFR, GLI1, GLI2, GLI3, Hedgehog, KRAS, TGF{\ss}, Tumormicroenvironment, Vismodegib",
author = "Hogenson, {Tara L.} and Olson, {Rachel L.O.} and Fernandez-Zapico, {Martin E}",
year = "2018",
month = "4",
day = "11",
doi = "10.1007/978-1-4939-7193-0_76",
language = "English (US)",
isbn = "9781493971916",
pages = "409--430",
booktitle = "Pancreatic Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Hedgehog signaling plays a dual role in pancreatic carcinogenesis

AU - Hogenson, Tara L.

AU - Olson, Rachel L.O.

AU - Fernandez-Zapico, Martin E

PY - 2018/4/11

Y1 - 2018/4/11

N2 - The hedgehog (Hh) pathway plays an important role in a wide variety of developmental processes including cellular differentiation and tissue patterning. While Hh signaling is a critical component of embryonic development, this pathway is not typically active in most adult tissues. Inappropriate Hh signaling has been associated with several types of malignancies including pancreatic ductal adenocarcinoma (PDAC). In PDAC, the Hh pathway is activated by two distinct mechanisms in the tumor epithelial and stromal compartments. In the stroma, the Hh pathway activity is induced by its ligands in a canonical fashion; in tumor epithelial cells its activity is regulated in a ligand-independent manner by known PDAC oncogenic cascades including KRAS, TGFß, and EGFR signaling. Initial preclinical studies demonstrated that the Hh pathway may be a promising therapeutic target for PDAC. However, Hh inhibition has not been successful in clinical trials of PDAC patients with advanced metastatic disease. Recent reports indicate the Hh pathway may play a dual role in carcinogenesis, acting as an oncogene in early tumorigenesis while switching to a tumor suppressor as the cancer progresses. Current research efforts are aimed at further understanding the role of the Hh pathway in all stages of carcinogenesis and defining the translational value of Hh inhibition in PDAC.

AB - The hedgehog (Hh) pathway plays an important role in a wide variety of developmental processes including cellular differentiation and tissue patterning. While Hh signaling is a critical component of embryonic development, this pathway is not typically active in most adult tissues. Inappropriate Hh signaling has been associated with several types of malignancies including pancreatic ductal adenocarcinoma (PDAC). In PDAC, the Hh pathway is activated by two distinct mechanisms in the tumor epithelial and stromal compartments. In the stroma, the Hh pathway activity is induced by its ligands in a canonical fashion; in tumor epithelial cells its activity is regulated in a ligand-independent manner by known PDAC oncogenic cascades including KRAS, TGFß, and EGFR signaling. Initial preclinical studies demonstrated that the Hh pathway may be a promising therapeutic target for PDAC. However, Hh inhibition has not been successful in clinical trials of PDAC patients with advanced metastatic disease. Recent reports indicate the Hh pathway may play a dual role in carcinogenesis, acting as an oncogene in early tumorigenesis while switching to a tumor suppressor as the cancer progresses. Current research efforts are aimed at further understanding the role of the Hh pathway in all stages of carcinogenesis and defining the translational value of Hh inhibition in PDAC.

KW - EGFR

KW - GLI1

KW - GLI2

KW - GLI3

KW - Hedgehog

KW - KRAS

KW - TGFß

KW - Tumormicroenvironment

KW - Vismodegib

UR - http://www.scopus.com/inward/record.url?scp=85054042167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054042167&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7193-0_76

DO - 10.1007/978-1-4939-7193-0_76

M3 - Chapter

SN - 9781493971916

SP - 409

EP - 430

BT - Pancreatic Cancer

PB - Springer New York

ER -